Teva shareholders may sue over EU Copaxone affair
Shareholders in Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) filed four petitions for discovery of documents in the Tel Aviv District Court last week, for the…
Browsing Tag
Copaxone
EU Copaxone interim antitrust findings hit Teva
In March 2021 the European Commission opened an official antitrust investigation to examine whether Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) had…
Israel sues Teva for $100m Copaxone royalties
The State of Israel today filed a lawsuit in the Lod District Court for $100 million against Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) claiming that the…